www.crexi.com - The Commercial Real Estate Exchange
Subscribe to Intelligence for full access
Analyze more property details including ownership and financial history. Share advanced property insights with your clients and teams.
Subscribe to Intelligence for full access
Analyze more property details including ownership and financial history. Share advanced property insights with your clients and teams.
31228965
31228966

1850 NW 69th Ave, Plantation, FL 33313

DM
FL FL SL3090637
Marcus & Millichap - Fort Lauderdale
CH
FL SL3623876
Marcus & Millichap - Fort Lauderdale
ZL
FL SL3497050
Marcus & Millichap - Fort Lauderdale
Listed by Marcus & Millichap - Fort Lauderdale
$10,260,000
72 days on market
Updated 72 days ago

GBI Biomanufacturing HQ

Details
APN 494134-41-0090
Property Type Industrial
Sub Type Manufacturing, R&D (+1)
Square Footage 38,000
Net Rentable (SqFt) 38,000
Units 1
Cap Rate 6%
NOI $615,626
Occupancy 100%
Tenancy Single
Lease Type NNN
Lease Term 10
Lease Expiration 05/31/2033
Remaining Term 7
Lease Options Two, 5-Year Renewal Options
Pro-Forma Cap Rate 9.84%
Pro-Forma NOI $1,009,480
Price per SqFt $270
Year Built 1980
Year Renovated 2023
Buildings 1
Stories 1
Acreage 2.300
Parking Spaces 103 spaces
Parking Per SqFt 2.71
Lease Commencement 06/01/2023
Ownership Fee Simple

Single-Tenant Biomanufacturing HQ | Mission-Critical Facility | 7 Year Term | Fort Lauderdale

Marketing description

GBI Biomanufacturing Headquarters, located at 1850 NW 69th Avenue in Plantation, Florida, a 38,000 square-foot biologics manufacturing and life sciences facility in Broward County. The property is fully leased to GBI Biomanufacturing, Inc., a contract development and manufacturing organization (CDMO) specializing in mammalian cell culture development and cGMP biologics production.

The asset is secured by a triple-net lease with approximately seven years of remaining term through May 31, 2033, providing stable cash flow while minimizing landlord responsibilities, as the tenant is responsible for taxes, insurance, operating expenses, and maintenance. The lease also includes 2.6 percent annual rent escalations, providing consistent income growth throughout the remaining primary lease term.

The facility supports highly specialized biologics manufacturing operations requiring tailored laboratory buildouts, advanced mechanical systems, and pharmaceutical-grade production infrastructure. GBI has invested approximately $26 million into the facility, demonstrating significant tenant commitment while creating substantial barriers to relocation.

The investment also offers a clear value-add component through the lease renewal structure. Upon the first renewal option, rent resets to 90 percent of prevailing market rent, representing over 40 percent mark-to-market rent upside based on current underwriting. This structure provides the ability to significantly increase income at the end of the primary term, producing a projected 9.84 percent cap rate in year seven.

Additionally, the property benefits from Florida’s recently enacted stem cell legislation, which allows certain regenerative treatments to be offered within the state and has helped increase demand for stem cell manufacturing capacity. GBI has indicated the expanded facility will support the production of up to one million stem cell units annually, positioning the asset within a rapidly growing segment of the biotechnology sector.

Investment highlights

  • TRIPLE-NET LEASE – SEVEN YEARS REMAINING: 100% leased to GBI Biomanufacturing through May 2033 with minimal landlord responsibilities.

  • VALUE-ADD OPPORTUNITY: Value-Add Opportunity - 9.84% Pro Forma Cap Rate.

  • NEW FLORIDA STEM CELL LEGISLATION: Recent state law enabling regenerative treatments supports increased demand for stem cell manufacturing capacity.

  • LIFE SCIENCES MANUFACTURING FACILITY: Specialized laboratory and biologics production infrastructure designed for pharmaceutical-grade operations.

  • STRATEGIC BROWARD COUNTY LOCATION: Central South Florida location with access to Sunrise Boulevard, Interstate 95, Florida’s Turnpike, and Fort Lauderdale-Hollywood International Airport.

  • MARK-TO-MARKET OPPORTUNITY: The tenant currently pays below-market rent of approximately $16.20/SF, compared to an estimated current market rent of $24.00/SF.

  • TENANT INVESTMENT IN FACILITY: Significant capital invested into specialized cGMP biologics manufacturing infrastructure, creating high relocation barriers.

Listing Contacts

DM
FL FL SL3090637
Marcus & Millichap - Fort Lauderdale
CH
FL SL3623876
Marcus & Millichap - Fort Lauderdale
ZL
FL SL3497050
Marcus & Millichap - Fort Lauderdale
Listed by Marcus & Millichap - Fort Lauderdale

Valuation Calculator

Login or Sign up to see Valuation Metrics
Sign up for Crexi to see valuation metrics for this property
$
$
%
Loan Amount
$0.00
Annual Debt Service
$--
$--
Annual Cash Flow
$615,626.00
$51,302.17/mo

Valuation Metrics

0
DSCR
6%
Cap Rate
6%
ROI

Map

Broker Selected Comps View More Comps

Property History

Intelligence Badge

Tax History

Intelligence Badge

Similar Properties

View All

Additional Information

Name
Douglas Mandel
License
FL SL3090637
Name
Cody Hershey
License
SL3623876
Brokerage
Marcus & Millichap
Title
Real Estate Broker
Brokerage Address
5900 North Andrews Avenue
*All information is deemed reliable but not guaranteed. Buyer to verify all information.
Is there information that looks off?
For assistance, reach out to our support team at [email protected] or call 888.273.0423 . For press inquiries, contact [email protected]
Equal Housing Opportunity
5510 Lincoln Blvd #400, Los Angeles, CA 90094Commercial Real Estate Exchange, Inc.Crexi Technologies, LLCCXTechnology, LLC
© 2026 Commercial Real Estate Exchange, Inc. All Rights Reserved. DRE #02086591